Research Articles
Two-Faced Nanocarriers: How Janus Dendrimers Are Revolutionizing Cancer Therapy
Explore how Janus dendrimers are transforming cancer treatment by delivering ibuprofen and chlorambucil simultaneously with precision targeting.
Golden Bullets: How Tiny Particles Are Revolutionizing Pancreatic Cancer Treatment
Exploring the revolutionary applications of gold nanoparticles in pancreatic cancer treatment through photothermal therapy, targeted drug delivery, and radiation enhancement.
The Invisible Detective: How Light Unlocks Rice's Nutritional Secrets
Discover how Near-Infrared Spectroscopy revolutionizes rice nutrition analysis, enabling non-destructive measurement of antioxidants in seconds.
The Self Code: Unlocking the Biological and Cognitive Origins of Identity
Exploring the evolutionary, developmental, and neurological foundations of human consciousness and self-identity through cutting-edge research.
Green Catalysts: Chiral Ionic Liquids Revolutionize Drug Synthesis
How immobilized chiral ionic liquids are transforming asymmetric Aza-Michael reactions for sustainable pharmaceutical synthesis
Light & Life: How Visible Light is Forging Tomorrow's Medicines, One Molecule at a Time
Discover how visible light-promoted synthesis is revolutionizing the creation of bioactive N,N-heterocycles for pharmaceutical applications.
Molecular Architects: How Trichloroacetimidate Chemistry and Aminosteroid SHIP Inhibitors Are Reshaping Drug Discovery
Breakthroughs in trichloroacetimidate etherification chemistry and aminosteroid SHIP inhibitors are solving long-standing challenges in pharmaceutical development.
The Green Dilemma: Cannabis in Cancer Care—Where Science Meets Stigma
Examining the scientific evidence for medical cannabis use in oncology patients for symptom management and potential anti-tumor effects.
Beyond Platinum: The Rise of Ruthenium in the Cancer Arms Race
Exploring how ruthenium complexes are emerging as promising alternatives to platinum-based cancer therapies with improved targeting and reduced side effects.
Bullseye on Cancer Cells: The Revolutionary Antibody Guiding Therapy to Tumors
Explore the groundbreaking Phase I trial of hu3S193, a humanized monoclonal antibody targeting Lewis-Y antigen in epithelial cancers. Learn about its precision targeting, pharmacokinetics, and future therapeutic potential.